Keiichi Inoue, PhD
Senior Scientist at Prevail Therapeutics
2007 NYSCF – Druckenmiller Fellow Alumnus
PhD, University of Tokyo, Japan
Postdoctoral Training, Columbia University
Dr. Inoue aimed to develop a therapy for Parkinson’s disease, which is caused by the progressive loss of dopamine cells in the brain. He isolated three genes that regulated the production of these dopamine cells from stem cells, making the process of obtaining dopamine cells more efficient. He also successfully generated mouse models that showed Parkinson’s-like symptoms such as the death of dopamine cells, providing an important resource for Parkinson’s disease researchers. Through these models, Dr. Inoue is helping scientists understand the disease mechanisms and validate potential therapies for Parkinson’s disease. He completed his postdoctoral studies at Columbia in Dr. Asa Abeliovich’s lab.